Rate My Professor Ian Alexander

Professor Alexander’s research specializations centre on gene therapy for genetic disorders of childhood, particularly liver diseases, employing genetically engineered viral vectors such as adeno-associated virus to repair or replace faulty genes. His team achieved Australia’s first gene therapy clinical trial for a genetic disease and has contributed significantly to understanding immune responses to gene therapeutics and advancing genome editing technologies. With over 290 peer-reviewed publications and more than 12,000 citations, his work has had substantial impact on the field. He is a Fellow of the Australian Academy of Health and Medical Sciences (FAHMS), recipient of the 2022 Peter Wills Medal from Research Australia for outstanding contributions to health and medical research, and has received prestigious NHMRC grants, including a top-ranked Ideas Grant. Professor Alexander contributes to clinical trial evaluations through the Kids Advanced Therapeutics program and fosters national collaboration for rare disease therapies.